These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 20331911)
61. Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers. Marchant NL; King SL; Tabet N; Rusted JM Neuropsychopharmacology; 2010 Apr; 35(5):1090-6. PubMed ID: 20072115 [TBL] [Abstract][Full Text] [Related]
62. The effect of an APOE polymorphism on cognitive function depends on age. Shin MH; Kweon SS; Choi JS; Lee YH; Nam HS; Park KS; Kim HN; Song HR; Kim BC; Choi SM; Oh SY; Jeong SK J Neurol; 2014 Jan; 261(1):66-72. PubMed ID: 24146255 [TBL] [Abstract][Full Text] [Related]
63. A cognitive phenotype for a polymorphism in the nicotinic receptor gene CHRNA4. Greenwood PM; Parasuraman R; Espeseth T Neurosci Biobehav Rev; 2012 Apr; 36(4):1331-41. PubMed ID: 22373960 [TBL] [Abstract][Full Text] [Related]
64. Imaging and cognitive genetics: the Norwegian Cognitive NeuroGenetics sample. Espeseth T; Christoforou A; Lundervold AJ; Steen VM; Le Hellard S; Reinvang I Twin Res Hum Genet; 2012 Jun; 15(3):442-52. PubMed ID: 22856377 [TBL] [Abstract][Full Text] [Related]
65. Individual response speed is modulated by variants of the gene encoding the alpha 4 sub-unit of the nicotinic acetylcholine receptor (CHRNA4). Schneider KK; Schote AB; Meyer J; Markett S; Reuter M; Frings C Behav Brain Res; 2015 May; 284():11-8. PubMed ID: 25639542 [TBL] [Abstract][Full Text] [Related]
66. The rs1277306 Variant of the REST Gene Confers Susceptibility to Cognitive Aging in an Elderly Taiwanese Population. Lin E; Tsai SJ; Kuo PH; Liu YL; Yang AC; Kao CF; Yang CH Dement Geriatr Cogn Disord; 2017; 43(3-4):119-127. PubMed ID: 28142142 [TBL] [Abstract][Full Text] [Related]
67. [Prognosis of the syndrome of mild cognitive impairment: the data of the biennial follow-up study]. Gavrilova SI; Fedorova IaB; Roshchina IF; Korovaĭtseva GI Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):4-10. PubMed ID: 17310789 [TBL] [Abstract][Full Text] [Related]
69. Polymorphism in the CHRNA4 gene is associated with rapid scene categorization performance. Kikuno Y; Matsunaga T; Saiki J Atten Percept Psychophys; 2013 Oct; 75(7):1427-37. PubMed ID: 23720086 [TBL] [Abstract][Full Text] [Related]
70. The role of the CHRNA4 gene in Internet addiction: a case-control study. Montag C; Kirsch P; Sauer C; Markett S; Reuter M J Addict Med; 2012 Sep; 6(3):191-5. PubMed ID: 22722381 [TBL] [Abstract][Full Text] [Related]
71. Genetic variation of CHRNA4 does not modulate attention in Parkinson's disease. Hudson G; Stutt A; Eccles M; Robinson L; Allcock LM; Wesnes KA; Chinnery PF; Burn DJ Neurosci Lett; 2010 Jul; 479(2):123-5. PubMed ID: 20493238 [TBL] [Abstract][Full Text] [Related]
72. Remarkable effect of transdermal nicotine in children with CHRNA4-related autosomal dominant sleep-related hypermotor epilepsy. Lossius K; de Saint Martin A; Myren-Svelstad S; Bjørnvold M; Minken G; Seegmuller C; Valenti Hirsch MP; Chelly J; Steinlein O; Picard F; Brodtkorb E Epilepsy Behav; 2020 Apr; 105():106944. PubMed ID: 32097883 [TBL] [Abstract][Full Text] [Related]
73. Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory. Greenwood PM; Lin MK; Sundararajan R; Fryxell KJ; Parasuraman R Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3633-8. PubMed ID: 19211801 [TBL] [Abstract][Full Text] [Related]
74. A novel differential susceptibility gene: CHRNA4 and moderation of the effect of maltreatment on child personality. Grazioplene RG; Deyoung CG; Rogosch FA; Cicchetti D J Child Psychol Psychiatry; 2013 Aug; 54(8):872-80. PubMed ID: 23240931 [TBL] [Abstract][Full Text] [Related]
76. Meta-analysis of age-related cognitive decline reveals a novel locus for the attention domain and implicates a COVID-19-related gene for global cognitive function. Acharya V; Fan KH; Snitz BE; Ganguli M; DeKosky ST; Lopez OL; Feingold E; Kamboh MI Alzheimers Dement; 2023 Nov; 19(11):5010-5022. PubMed ID: 37089073 [TBL] [Abstract][Full Text] [Related]
77. Normal genetic variation, cognition, and aging. Greenwood PM; Parasuraman R Behav Cogn Neurosci Rev; 2003 Dec; 2(4):278-306. PubMed ID: 15006290 [TBL] [Abstract][Full Text] [Related]
78. Mutation screening of the CHRNA4 and CHRNB2 nicotinic cholinergic receptor genes in Alzheimer's disease. Steinlein OK; Stoodt J; de Vos RA; Steur EN; Wevers A; Schütz U; Schröder H Neuroreport; 1999 Sep; 10(14):2919-22. PubMed ID: 10549797 [TBL] [Abstract][Full Text] [Related]
79. Hospitalization and effects on cognition. Rockwood K Neurology; 2012 Mar; 78(13):e86-7. PubMed ID: 22454274 [No Abstract] [Full Text] [Related]
80. Correction to: The influence of APOE status on rate of cognitive decline. Morrison C; Oliver MD; Berry V; Kamal F; Dadar M Geroscience; 2024 Jun; 46(3):3509-3510. PubMed ID: 38400875 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]